29412 Federal Register / Vol. 61, No. 112 / Monday, June 10, 1996 / Notices

7. Development of an internship

program for students in schools of

public health to learn about the federal

public health system. For example,

developing an internship and mentoring

program for masters of public health

and masters of health sciences students

during their academic preparation.

Federal Involvement

The Cooperative Agreement

mechanism is being used for this project

to allow for substantive Federal

programmatic involvement in the

development of the details of the

Cooperative Agreement.

Substantive Federal programmatic

involvement will occur through Federal

membership on the Steering Committee

representing the Health Resources and

Services Administration, including the

Bureau of Health Professions, Bureau of

Health Resources Development, Bureau

of Primary Health Care, Maternal and

Child Health Bureau, and the Office of

Public Health Practice. The involvement

primarily would be in the following

areas:

• participation in the identification of

emerging health management practice

issues for technical assistance purposes;

• identification of HRSA

programmatic issues for special

attention through the Cooperative

Agreement;

• identification of appropriate

consultation for the proposed projects;

• assistance in defining the objective,

method, evaluation and use of project

results and translation into the

knowledge, skills, and attributes for

educational objectives;

• assistance in ensuring appropriate

linkages with public health practice and

health care delivery sites;

• assistance in creating linkages to

appropriate professional associations in

the Washington, D.C. area;

• participation in the review and

selection of contracts and agreements

developed in implementing the project;

(and)

• participation in monitoring the

implementation, conduct and results of

projects implemented under the

Cooperative Agreement.

Eligibility for Funding

Entities eligible for funding under this

Cooperative Agreement must:

1. be a recognized professional

association representing schools of

public health, and

2. be located in the Washington, D.C.

metropolitan area.

National Health Objectives for the Year

2000

The Public Health Service (PHS) urges

applicants to submit work plans that

address specific objectives of Healthy

People 2000. Potential applicants may

obtain a copy of Healthy People 2000

(Full Report; Stock No. 017–001–00474–

0) or Healthy People 2000 (Summary

Report; Stock No. 017–001–00473–1)

through the Superintendent of

Documents, Government Printing

Office, Washington, D.C. 20402–9325

(Telephone (202) 783–3238).

Education and Service Linkage

As part of its long-range planning,

HRSA will be targeting its efforts to

strengthening linkages between U.S.

Public Health Service education

programs which provide comprehensive

primary care services to the

underserved.

Smoke-Free Workplace

The Public Health Service strongly

encourages all grant recipients to

provide a smoke-free workplace; to

promote the non-use of all tobacco

products; and to promote Public Law

103–227, the Pro-Children Act of 1994,

which prohibits smoking in certain

facilities that receive Federal funds in

which education, library, day care,

health care, and early childhood

development services are provided to

children.

Review Criteria

Applications received will be

reviewed by an ad hoc review panel

using the following criteria:

• the degree to which the proposal

contains clearly stated, realistic, crosscutting, achievable, and measurable

objectives;

• the extent to which the proposal

includes an integrated methodology

compatible with the scope of project

objectives, including collaborative

relationships with relevant institutions

and professional associations;

• the administrative and management

capability of the applicant to carry out

the Cooperative Agreement; and

• the extent to which budget

justifications are complete, appropriate,

and cost-effective.

Application Requests

Eligible entities interested in

receiving materials regarding this

program should notify HRSA. Materials

will be sent only to those entities

making a request. Requests for proposal

instructions and other questions should

be directed to: Mr. John R. Westcott,

Grants Management Officer, Bureau of

Health Professions, HRSA, 5600 Fishers

Lane, Room 8C–26, Rockville, Maryland

20857, Telephone: (301) 443–6880.

Completed applications must be

returned to the Grants Management

Officer at the above address.

Questions concerning programmatic

aspects of the Cooperative Agreement

must be directed to:

Ronald B. Merrill, M.H.A., Chief, Public

Health Branch, Division of

Associated, Dental and Public Health

Professions, Bureau of Health

Professions, HRSA, 5600 Fishers

Lane, Room 8C–09, Rockville,

Maryland 20857, Telephone: (301)

443–6896

Alexander F. Ross, Sc.D., Office of

Public Health Practice/HRSA,

Parklawn Building, Room 14–15, 5600

Fishers Lane, Rockville, Maryland

20857, Telephone: (301) 443–4034

Paperwork Reduction Act

The standard application form PHS

6025–1, HRSA Competing Training

Grant Application, have been approved

by the Office of Management and

Budget (OMB) under the Paperwork

Reduction Act. The OMB clearance

number is 0915–0060.

The deadline date for receipt of

application is July 10, 1996.

Applications will be considered to be

‘‘on time’’ is they are either:

1. Received on or before the

established deadline date, or

2. Sent on or before the established

deadline date and received in time for

orderly processing. (Applicants should

request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or U.S. Postal Service. Private metered

postmarks shall not be acceptable as

proof of timely mailing.)

Late applications not accepted for

processing will be returned to the

applicant. In addition, applications

which exceed the page limitation and/

or do not follow format instructions will

not be accepted for processing and will

be returned to the applicant.

This program is not subject to the

provisions of Executive Order 12372,

Intergovernmental Review of Federal

Programs (as implemented through 45

CFR part 100). This program is also not

subject to the Public Health System

Reporting Requirements.

Dated: June 3, 1996.

Ciro V. Sumaya,

Administrator.

[FR Doc. 96–14588 Filed 6–7–96; 8:45 am]

BILLING CODE 4160–15–P
Federal Register / Vol. 61, No. 112 / Monday, June 10, 1996 / Notices 29413

Public Health Service

National Toxicology Program (NTP)

Board of Scientific Counselors’

Meetings; Announcement of NTP Draft

Technical Reports Projected for Public

Review From December 1996 Through

Fall 1998; Request for Public Input

To earlier inform the public and

encourage interested parties to comment

or obtain information on projected longterm toxicology and carcinogenesis

studies prior to public peer review, the

National Toxicology Program (NTP)

again publishes in the Federal Register

a current listing of draft Technical

Reports projected for evaluation by the

NTP Board of Scientific Counselors’

Technical Reports Review

Subcommittee during their next five

meetings from December 1996 through

Fall 1998. We plan to continue updating

the listing with announcements in the

Federal Register once or twice a year.

The next meeting dates are December

11–12, 1996. Specific dates for 1997 and

1998 meetings will be established at a

later time.

The attached Table 1 lists draft

Technical Reports for long-term studies

on chemicals within known or

approximate dates of reviews and

includes Chemical Abstracts Service

(CAS) registry numbers, primary use,

route of administration, species,

exposure levels, and NTP report

numbers (if assigned).

Technical Reports of short-term

toxicity studies are currently reviewed

by mail; however, they may be reviewed

in open meetings when necessary. The

attached Table 2 lists the draft

Technical Reports of short-term toxicity

studies tentatively projected for review

by mail from April 1996 to December

1996 and also includes Chemical

Abstracts Service (CAS) registry

numbers, primary use, route of

administration, species, exposure levels,

and NTP report numbers (if assigned).

Those interested in having more

information about any of the studies

listed in this announcement should

contact Central Data Management as

early as possible by telephone or by

mail at: MD E1–02, NIEHS, P.O. Box

12233, Research Triangle Park (RTP),

North Carolina 27709 (919/541–3419).

The program would welcome receiving

toxicology and carcinogenesis data from

completed, ongoing or planned studies

by others as well as current production

data, human exposure information, and

use and use patterns.

The Executive Secretary, Dr. Larry G.

Hart, P.O. Box 12233, Research Triangle

Park, North Carolina 27709, telephone

919/541–3971, FAX 919/541–0295 will

furnish final agendas and other program

information prior to a meeting, and

summary minutes subsequent to a

meeting.

Attachments

Dated: May 21, 1996.

Kenneth Olden,

Director, National Toxicology Program.

TABLE 1.—SUMMARY DATA FOR TECHNICAL REPORTS SCHEDULED FOR REVIEW AT THE MEETING OF THE NTP BOARD OF

SCIENTIFIC COUNSELORS’ TECHNICAL REPORTS REVIEW SUBCOMMITTEE FROM DECEMBER 1996 THROUGH 1998

Chemical name/cas No. Use Route Species Exposure levels

Chemicals Tentatively Scheduled for Peer Review

December 11–12, 1996:

3′-Azido-3′ -Deoxythymidine (AIDS):

30516–87–1 ......................................................... PHAR ..... GAV ....... RM ......... Mice only: 0, 30, 60, or 120 mg/kg; 50/sex.

Chloroprene:

126–99–8 ............................................................. PLAS ..... INHAL .... RM ......... R&M: 0, 12.8, 32.0, or 80.0 ppm; 50/sex/species/

group.

Cobalt Sulfate Heptaphydrate:

10026–24–1 ......................................................... PNT ....... INHAL .... RM ......... R&M: 0, 0.3, 1.0, or 3.0 mg/m3; 50/sex/species/

group.

Ethylbenzene:

100–41–4 ............................................................. RUBR .... INHAL .... RM ......... R&M: 0, 75, 250, or 750 ppm (50/sex/species/

group).

Interferon AD + 3′-Azido-3′ -Deoxythymidine:

(AIDS) .................................................................. PHAR ..... SC&GV MM ......... Dual routes with both compounds: AZT: 0, 30, 60, or

120 (gav) mg/kg; IFN: 500 or 5000 units 3X/week.

Isobutyraldehyde:

78–84–2 ............................................................... INTR ...... INHAL .... RM ......... R&M: 0, 500, 1000, or 2000 ppm (50/sex/species/

group).

Oxazepam:

604–75–1 ............................................................. PHAR ..... FEED ..... R ............ 0, 625, 1250, 2500, 5000, or 10,000 ppm; 50/sex/

group.

Polyvinyl alcohol:

9002–89–5 ........................................................... PHAR ..... IVAG ...... M ............ 25% PVA, vehicle, untreated; 100/group.

Primaclone (Primidone):

125–33–7 ............................................................. PHAR ..... FEED ..... RM ......... M: 0, 0.03, 0.06, or 0.13% R: 0, 0.06, 0.13, or

0.25% (50/sex/species).

Tetrahydrofuran:

109–99–9 ............................................................. SOLV ..... INHAL .... RM ......... R&M: 0, 200, 600, or 1800 ppm (50/sex/species/

group).

Theophylline:

58–55–9 ............................................................... PHAR ..... GAV ....... RM ......... R: 7.5, 25, or 75 mg/kg; 50/group fm: 7.5, 25, or 75

mg/kg; 50/group mm: 15, 50, or 150 mg/kg; 50/

group.

Chemicals Tentatively Scheduled for Peer Review in

Summer 1997:

1-Chloro-2-Propanol, Technical:

127–00–4 ............................................................. INTR ...... WATER RM ......... R: 0, 150, 325, or 650 ppm M: 0, 250, 500, or 1000

ppm (50/sex/group).
29414 Federal Register / Vol. 61, No. 112 / Monday, June 10, 1996 / Notices

TABLE 1.—SUMMARY DATA FOR TECHNICAL REPORTS SCHEDULED FOR REVIEW AT THE MEETING OF THE NTP BOARD OF

SCIENTIFIC COUNSELORS’ TECHNICAL REPORTS REVIEW SUBCOMMITTEE FROM DECEMBER 1996 THROUGH 1998—

Continued

Chemical name/cas No. Use Route Species Exposure levels

Coconut Oil Acid Diethanolamine Condensate:

68603–42–9 ......................................................... TEXL ...... SP .......... RM ......... R: 0, 50, or 100 mg/kg M: 0, 100, or 200 mg/kg (50

sex/species/group).

Diethanolamine:

111–42–2 ............................................................. TEXL ...... SP .......... RM ......... MR: 0, 16, 32, or 64 mg/kg; FR: 0, 8, 16, or 32 mg/

kg; Mice: 0, 40, 80, or 160 mg/kg (50/sex/species/

group).

Furfuryl alcohol:

98–00–0 ............................................................... FOOD .... INHAL .... RM ......... R&M: 0, 2, 8, or 32 ppm (50/sex/species/group).

Lauric Acid Diethanolamine Condensate:

120–40–1 ............................................................. DTRG .... SP .......... RM ......... R: 0, 50, or 100 mg/kg M: 0, 100, or 200 mg/kg (50/

sex/species/group).

Oleic Acid Diethanolamine Condensate:

93–83–4 ............................................................... COSM .... SP .......... RM ......... R: 0, 50, or 100 mg/kg; 50/sex/group M: 0, 15, or 30

mg/kg; 55/sex/group.

Pyridine:

110–86–1 ............................................................. SOLV ..... WATER RMR ...... R: 0, 100, 200, or 400 ppm MM: 0, 250, 500, or

1000 ppm FM: 125, 250, or 500 ppm MWR: 0,

100, 200, or 400 ppm (50/sex/group).

Chemicals Tentatively Scheduled for Peer Review

Fall 1997:

Ethylene Glycol Monobutyl Ether (EGMBE):

111–76–2 ............................................................. SOLV ..... INHAL .... RM ......... R: 0, 31, 62.5, or 125 ppm M: 0, 62.5, 125, or 250

ppm; 50/sex/species.

Isobutene:

115–11–7 ............................................................. RUBR .... INHAL .... RM ......... R&M: 0, 500, 2000, or 8000 ppm (50/sex/species/

group).

Isoprene:

78–79–5 ............................................................... RUBR .... INHAL .... R ............ R: 0, 220, 700, or 7000 ppm; 50/sex/group.

Pentachlorophenol, purified:

87–86–5 ............................................................... PEST ..... FEED ..... R ............ R: 0, 200, 400, or 600 ppm; 50/sex/group—1000

ppm stop study (60/sex).

Chemicals Tenatively Scheduled for Peer Review

Summer 1998:

Gallium Arsenide:

1303–00–0 ........................................................... ELEC ..... INHAL .... RM ......... R: 0, 0.01, 0.1, or 1.0 mg/m3; 50/sex/group M: 0,

0.1, 0.5, or 1.0 mg/m3; 50/sex/group.

Methyleugenol:

93–15–2 ............................................................... FOOD .... GAV ....... RM ......... R&M: 0, 37, 75, or 150 mg/kg (50/sex/species/

group).

Oxymetholone:

434–07–1 ............................................................. PHAR ..... GAV ....... RM ......... MR: 0, 3, 30, or 150 mg/kg; FR: 0, 3, 30, or 100 mg/

kg.

Chemicals Tentatively Scheduled for Peer Review

Fall 1998:

Indium Phosphide:

22398–80–7 ......................................................... ELEC ..... INHAL .... RM ......... R&M: 0, 0.03, 0.1, or 0.3 mg/m3.

TABLE 2.—SHORT-TERM TOXICITY STUDIES SCHEDULED FOR REVIEW BY THE NTP BOARD OF SCIENTIFIC COUNSELORS’

TECHNICAL REPORTS REVIEW SUBCOMMITTEE FROM APRIL 1996 THROUGH 1998

Chemical name/CAS No. Use Route Species Exposure levels

Short-Term Toxicity Studies Tentatively Scheduled

for Peer Review April 1996:

Magnetic Fields (EMF):

Electromag .......................................................... ELEC ..... WB ......... RM ......... 60 hz magnetic fields—20 mg, 58 2g, 10 g continuous and 10 g intermittent; 10/group.

Methacrylonitrile:

126–98–7 ............................................................. PLAS ..... GAV ....... RM ......... R: 0, 7.5, 15.0, 30.0, 60.0, 120.0 47 mg/kg/day; M:

0, 0.75, 1.5, 3.0, 6.0, 12.0 mg/kg/day; Rats: 20/

grp; mice: 10/grp.

Methapyrilene Hydrochloride:

135–23–9 ............................................................. PHAR ..... FEED ..... R ............ Male Rats: 0, 50, 100, 250, 46 1000 ppm; 40/grp.
Federal Register / Vol. 61, No. 112 / Monday, June 10, 1996 / Notices 29415

TABLE 2.—SHORT-TERM TOXICITY STUDIES SCHEDULED FOR REVIEW BY THE NTP BOARD OF SCIENTIFIC COUNSELORS’

TECHNICAL REPORTS REVIEW SUBCOMMITTEE FROM APRIL 1996 THROUGH 1998—Continued

Chemical name/CAS No. Use Route Species Exposure levels

Short-Term Toxicity Studies Tentatively Scheduled

for Peer Review May 1996:

M-Chloroaniline:

108–42–9 ............................................................. INTR ...... GAV ....... RM ......... R&M 0, 10, 20, 40, 80, 160 43 mg/kg, 20/grp (rats);

10/grp (mice).

O-Chloroaniline:

95–51–2 ............................................................... DYE ....... GAV ....... RM ......... R&M 0, 10, 20, 40, 80, & 160 43 mg/kg, 20/grp

(rats); 10/grp (mice).

Short-Term Toxicity Studies Tentatively Scheduled

for Peer Review June 1996:

AZT+Methadone HCL (AIDS):

Aztmethcomb ....................................................... PHAR ..... GAV ....... MM ......... AZT: 200, 400, or 800 mg/kg/day with Methadone

HCL: 5, 15, or 30 mg/kg/day.

2′, 3′-Dideoxycytidine (AIDS initiative):

7481–89–2 ........................................................... PHAR ..... GAV ....... MM ......... Female mice only: 500, 1000 mg/kg/day.

3, 3′, 4, 4′-Tetrachloroazobenzene:

14047–09–7 ......................................................... HERB ..... GAV ....... RM ......... R&M: 0, 0.1, 1.0, 3.0, 10, or 30 mg/kg body weight

(M&F; 10/group).

1, 1, 2, 2-Tetrachloroethane ....................................... SOLV ..... GAV ....... RM .........

1, 1, 2, 2-Tetrachloroethane:

79–34–5 ............................................................... SOLV ..... MICRO ... RM ......... R&M; R:untreated control, vehicle control, 18, 37,

75, 150, or 300 mg/kg body wt/day; M: untreated

control, vehicle control, 88, 175, 350, 700, or 1400

mg/kg body wt/day; 10/group/sex.

Short-Term Toxicity Studies Tentatively Scheduled

for Peer Review August 1996:

1, 1, 1-Trichloroethane:

71–55–6 ............................................................... SOLV ..... MICRO ... RM ......... R&M: 0, 0.5, 1.0, 2.0, 4.0, 41 and, 8.0% (10/S/S).

Short-Term Toxicity Studies Tentatively Scheduled

for Peer Review December 1996:

CIS & TRANS 1,2-Dichloroethylene:

540–59–0 ............................................................. SOLV ..... MICRO ... RM ......... 55.

CIS-1, 2-Dichloroethylene:

156–59–2 ............................................................. SOLV ..... MICRO ... RM ......... 55.

TRANS-1, 2-Dichloroethylene:

156–60–5 ............................................................. SOLV ..... MICRO ... RM ......... 55.

TRANS-1, 2-Dichloroethylene:

156–60–5 ............................................................. SOLV ..... GAV ....... RM ......... 55.

TRANS-1, 2-Dichloroethylene:

156–60–5 ............................................................. SOLV ..... MICRO ... RM ......... R&M: untreated control, vehicle control, 3125, 6250,

12,500, 25,000, or 50,000 ppm; 10/group/sex.

Abbreviations used: in this report:

Use Primary use category

COMT Contaminates and/or Impurities.

COSM Cosmetics, Perfumes, Fragrances,

Hair Preparations.

DTRG Detergents and Cleaners.

DYE .... As or in Dyes, Inks, and Pigments.

ELEC In Electrical and/or Dielectric Systems.

FOOD Food, Beverages, or Additives.

HERB Herbicide(s).

INTR ... Chemical Intermediate or Catalyst.

PEST Pesticides, General or Unclassified.

PHAR Pharmaceuticals or Intermediates.

PLAS ... As or in Plastics.

PNT ..... Paint Ingredient.

RUBR Rubber Chemical.

SOLV Vehicles and Solvents.

TEXL ... In Manufacture of Textiles.

Route Route of administration

FEED Dosed-Feed.

GAV .... Gavage.

Route Route of administration

INHAL Inhalation.

IP/IJ ..... Intraperitoneal Injection.

IVAG ... Intravaginal.

MICRO Microencapsulation in Feed.

SC&GV Subcutaneous Inj.+Gavage.

SP ....... Topical.

WATER Dosed-Water.

WB ...... Whole Body Exposure.

Spec Species

R .......................... = Rats.

M .......................... = Mice.

[FR Doc. 96–14149 Filed 6–7–96; 8:45 am]

BILLING CODE 4140–01–M

Substance Abuse and Mental Health

Services Administration

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

Periodically, the Substance Abuse and

Mental Health Services Administration

(SAMHSA) will publish a list of

information collection requests under

OMB review, in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

documents, call the SAMHSA Reports

Clearance Officer on (301) 443–0525.

FY 1997/1998 Substance Abuse

Prevention and Treatment Block Grant

Application Format—Revision of a

currently approved collection—The

Public Health Service Act (42 U.S.C.

300x 1–9) authorizes block grants to

States for the purpose of providing

prevention and treatment services.